Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

Deals > All

Total search results: 10233 | Ordered by Date (ascending)
1 2 3 ... 101 102 103  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Advancell–Apple Tree Communications: public relations, 201504 communication services by Apple Tree Communications
AES Laboratoire–Mérieux: investment, 201105 acquisition €183m of AES Laboratoire/AES Chemunex by bioMérieux
Agilent–Univ Duisburg-Essen: analytical technology, 201804– collab with new Agilent sponsored Teaching + Research Center for Separation (TRC) at UDE
AiCuris–SEVERAL: investment, 201004 financing round Series B €55m from existing investors led by Santo Holding
Almirall–AB-Biotics: genetic test, 201304 collab existent commercialization of Neurofarmagen developed by AB-Biotics
Applied Physics–Atlas-Werke: analytical instruments, 1963– mutual marketing/selling agreem with Atlas MAT GmbH
Bionaturis–BBD Biophenix: investment, 201406 Bionaturis acquires BBD Biophenix S.L., accquisition by Bionaturis S.A.
Biotest–Merck (DE): investment, 201103 acquisition of Biotest microbiology business incl heipha Dr Müller GmbH + Hycon by Merck
Cellerix–Ysios Capital: investment, 200709 Ysios co-leads €27,2million Series B financing of stem cell company Cellerix
Cellestia Biotech–SEVERAL: investment, 201701 seed financing round Series C CHF5.2m from Sotio/PPF Group + private investors
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series A CHF0.5m
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series B CHF2.3m
Clearstone Central Laboratories–LabCorp: investment, 201106– acquisition €na announced
Cnio–Piniés & Aguilar: public relations, 201504 service existent by Piniés & Aguilar
Eckert & Ziegler–Eckert Wagniskapital: investment, 19?? founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Endomagnetics–SEVERAL: investment, 201807 financing round Series C $10m (£8m) led by new investor Draper Esprit
Enterome–Gustave Roussy: cancer immunotherapy, 201511– collab microbiome-based drug development
Enterome–SEVERAL: investment, <2012 seed financing round €1.5m Seventure Partners + INRA Transfert
Eppendorf–Clemens: thermocycler, before 2009 supply OEM production of PCR devices for Eppendorf
Greenovation–Zukunftsfonds Heilbronn: investment, 201105 existent Greenovation listed as part of portfolio
Invivo Corp–MeVis: image analysis software, –<200810 collab development DynaCAD software solution
Life Length–Piniés & Aguilar: public relations, 201504 service existent by Piniés & Aguilar
ProQR Therapeutics–SEVERAL: investment, 201711 public offering + concurrent direct offering $20.79m at $3.25/share
Proteome Sciences–SEVERAL: investment, 201402 placing £5m of 18.86m new ordinary shares 28p/share
Qiagen–HandyLab: HandyLab sample extraction technology, 200904– license for automated HPV screening solution
Qiagen–TVM: investment, <200502 investment 5.5DM several years before 2/05
R-Biopharm–EuroProxima: research antibodies, 201710 acquisition of research antibody line from EuroProxima BV by Progen Biotechnik GmbH
SimplicityBio–TATAA Biocenter: biomarker services, 201610– collab product integration to offer complete biomarker solutions
Sprout Pharmaceuticals–Boehringer: flibanserin, <201303 acquisition of flibanserin from Boehringer Ingelheim
Veterindustria–Triada: public relations, 201504 service existent by Triada Comunicación y Relaciones Públicas
ZIM Plant Technology–Yara: investment, 201311–201401 acquisition by Yara
IUL Instruments–Fluxion Biosciences: BioFlux product line, 200810– distribution excl in Austria (+ Germany) by IUL Instruments GmbH 0200-12-10
IUL Instruments–Fluxion Biosciences: BioFlux product line, 200810– distribution excl in Germany (+ Austria) by IUL Instruments GmbH 0200-12-10
Bayer–Atlas-Werke: MS1 mass spectrometer, 1948c supply purchase of modified prototype instrument from Atlas MAT 1948-01-01
Univ Heidelberg–Atlas-Werke: CH-4 mass spectrometer, 1964 supply installation Atlas MAT CH-4 at Mass Spectrometry Facility at OCI 1964-01-01
Univ Alberta–Kratos: mass spectrometer, 197505 supply purchase Kratos Analytical MS-50G by Dept Chemistry MS Facility 1975-05-01
Columbus Pharmaceutical–Boehringer: investment, 1978 acquistion by Boehringer + renamed Roxane Laboratories Inc 1978-01-01
Roche–Hitachi: immunoassay analyser, 1978– collab strategic alliance developm + production of instruments + automated workflows 1978-01-01
Bruker-Franzen Analytik–Bruker (DE): investment, 1980 acquisition by company Bruker from Karlsruhe (DE) 1980-01-01
Waters–Millipore: investment, 198005 merger acquisition 1980-05-01
Altair–Pharmacia AB: laboratory equipment, 1983– distribution Altair becomes distributor in Japan for Pharmacia (SE) 1983-01-01
Carlo Erba–Fisons: investment, 1985 acquisition of Carlo Erba Strumentazione SpA by Fisons plc 1985-01-01
API Systems–Mérieux: investment, 1987 acquisition by bioMèrieux 1987-01-01
Univ Alberta–Kratos: mass spectrometer, 198802 supply purchase Kratos Analytical MS-50B by Dept Chemistry MS Facility 1988-02-01
Kratos–Shimadzu: investment, 1989 acquisition of Kratos Group plc by Shimadzu 1989-01-01
Nordisk Gentofte– Novo Industri: investment, 1989 merger new name Novo Nordisk A/S 1989-01-01
Roche–Sigma-Aldrich: investment, 1989 acquisition of Fluka from Roche + Ciba-Geigy by Sigma-Aldrich 1989-01-01
Univ Bonn–Shimadzu: mass spectrometer, 1989 supply purchase Concept 1H by Mass Spec Lab of Kékule Institute from Kratos Karlsruhe 1989-01-01
Bruker Daltonics–Germany (govt): grant, 198907–199206 grant €394.3k for Bruker Daltonik GmbH for emission mass spectrometer from BMBF 1989-07-01
Bruker Daltonics–Germany (govt): grant, 198912–199306 grant €653.6k to Bruker Daltonik GmbH for developm laser mass spectrometer from BMBF 1989-12-01
Cambridge Instruments–Wild Leitz: investment, 1990 merger to form Leica group 1990-01-01
Commonwealth Holdings–MassMutual: investment, 1990 acquisition $150m of Oppenheimer Management Corp from British & Commonwealth Holdings plc 1990-01-01
VG Instruments–Fisons: investment, 1990 acquisition 1990-01-01
Brechbühler–Phenomenex: chromatography consumables, 1991–201708 distribution in Switzerland by Brechbühler TERMINATED 9/17 1991-01-01
Bruker Daltonics–Germany (govt): grant, 199107–199412 grant €376.7k to Bruker Daltonik GmbH from BMBF 1991-07-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT SSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-700 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Bruker Daltonics–Germany (govt): grant, 199407–199706 grant €2.27m Bruker Daltonik GmbH for developm mass spectrometry in genome research from BMBF 1994-07-01
Immunotech–Coulter: investment, 1995 acquisition 1995-01-01
Techlab–DataApex: chromatography s/w, 1995– distribution of Clarity s/w by Techlab GmbH 1995-01-01
Univ Heidelberg–Bruker Daltonics: mass spectrometer, 199508 supply installation Biflex MALDI-TOF at Mass Spectrometry Facility 1995-08-01
Flamel Technologies–SEVERAL: investment, 1996 IPO €49m at Nasdaq 1996-01-01
OTHER–MasCom: investment, 1996 acquisition of company NN specialising in manufacture of multipliers by MasCom 1996-01-01
Plasmatec–Axis-Shield: investment, 1996 acquisition of company 1996-01-01
Rhône-Poulenc–Thermo Electron: investment, 199603 acquisition of Fisons Scientific Instruments by Thermo Instrument 1996-03-01
Univ Heidelberg–JEOL: mass spectrometer, 199604 supply installation JMS-700 magnetic sector at Mass Spectrometry Facility 1996-04-01
Bruker Daltonics–MasCom: MS multiplier, 1997– supply OEM by MasCom for Bruker in Bremen 1997-01-01
DeveloGen–TVM: investment, 1997 initial investment by TVM 1997-01-01
Siemens–Bruker (DE): investment, 1997 acquisition X-ray analysis business new company called Bruker AXS 1997-01-01
Thermo Electron–MasCom: MS multiplier, 1997– supply OEM by MasCom for ThermoFinnigan in Bremen 1997-01-01
Univ Leeds–Waters: mass spectrometer, 1997 supply purchase of Platform II system by Astbury Centre Mass Spec Lab w Wellcome Trust grant 1997-01-01
Bruker Daltonics–Germany (govt): grant, 199706–200101 grant €2.42m Bruker Daltonik GmbH for mass spec analyzer for DNA polymorphisms from BMBF 1997-06-01
Novartis–Yoshitomi Pharmaceutical: fingolimod, 199709– license ww for immunosuppressant FTY720 1997-09-24
MeVis–Germany (govt): grant, 199710–200003 grant €631.9k for MeVis gGmbH for computer-based system for breast diagnostics from BMBF 1997-10-01
Eurofins–SEVERAL: investment, 199710 IPO 1997-10-24
Ludwig Institute–Bruker Daltonics: mass spectrometer, 1997 supply purchase Biflex MALDI-ToF-MS as 1st mass spectrometer of Hellman Group 1997-12-01
Boehringer Mannheim–Roche: investment, 1998 acquisition by Roche 1998-01-01
Diagnostic Medical Systems–SEVERAL: investment, 1998 IPO at Euronext 1998-01-01
Dima–Meikang Biotech: rapid diagnostics, 1998– distribution of lateral flow quick tests in Europe by Dima GmbH 1998-01-01
TopLab–Aventis: investment, 1998 Aventis R&D acquires 24.7% in connection with strategic partnership 1998-01-01
Transgene–SEVERAL: investment, 1998 IPO €61.4m at Euronext 1998-01-01
Univ Bonn–Thermo Electron: mass spectrometer, 1998 supply purchase MAT 95 XL by Mass Spec Lab of Kékule Institute from Thermo Finnigan Bremen 1998-01-01
Univ Ulm–Bruker Daltonics: mass spectrometer, 1998 supply Bruker Daltonics REFLEX III MALDI-TOF accord to web site of Service Center Mass Spec 1998-01-01
Bruker Daltonics–Germany (govt): grant, 199805–200004 grant €74.6k for developm laser mass spectrometer for online analysis from BMBF 1998-05-01
Stallergenes–SEVERAL: investment, 1998 IPO at Euronext 1998-07-01
Enanta Pharmaceuticals–TVM: investment, 1999 initial investment of TVM 1999-01-01
Georgia Tech–Waters: mass spectrometer, 1999 supply Micromass Quattro LC installed 1999-01-01
Georgia Tech–Waters: mass spectrometer, 1999 supply Micromass TofSpec2E installed 1999-01-01
Medigene–Epitome Pharmaceuticals: Veregen, 1999– acquisition of basic rights to active substance catechin extract by Medigene 1999-01-01
Univ Leeds–Waters: mass spectrometer, 1999 supply purchase of Q-Tof system by Astbury Centre Mass Spec Lab w JREI grant + Univ Leeds + Micromass 1999-01-01
Spectral-Physics–Thermo Electron: investment, 199902 acquisition by Thermo Instrument 1999-02-01
Evolva–SEVERAL: investment, 200910 financing round Series B 1st tranche CHF28m 1999-10-22
Evolva–SEVERAL: investment, 200912 financing round Series B 2nd tranche CHF16m incl new + lead investor Entrepreneurs Fund 1999-10-22
Evolva–Ventureast: investment, 200912– commitment to invest CHF5m in Evolva Biotech Pvt Ltd by Ventureast Trustee Co Pvt Ltd 1999-10-22
Nicox–SEVERAL: investment, 199911 IPO €33.2m at Euronext 1999-11-03
CLIB 2021 Cluster–Protagen: industrial biotechnology, 2010 collab Protagen is project partner of CLIB 2021 2000-01-01
CyDex–TVM: investment, 2000 initial investment by TVM 2000-01-01
HD Technologies–Thermo Electron: investment, 200001 acquisition of HD Technologies Ltd by Thermo Finnigan (Masslab Ltd) 2000-01-01
OncoTyrol project–Protagen: cancer diagnostics, 2010 collab existent Protagen is project partner of OncoTyrol 2000-01-01
1 2 3 ... 101 102 103  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top